SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-240472
Filing Date
2021-08-09
Accepted
2021-08-09 16:19:29
Documents
99
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d584537d10q.htm   iXBRL 10-Q 1473702
2 EX-31.1 d584537dex311.htm EX-31.1 7284
3 EX-31.2 d584537dex312.htm EX-31.2 7275
4 EX-32.1 d584537dex321.htm EX-32.1 4904
  Complete submission text file 0001193125-21-240472.txt   7530820

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA orgo-20210630.xsd EX-101.SCH 63476
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orgo-20210630_cal.xml EX-101.CAL 58126
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orgo-20210630_def.xml EX-101.DEF 380003
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20210630_lab.xml EX-101.LAB 499092
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20210630_pre.xml EX-101.PRE 490867
10 EXTRACTED XBRL INSTANCE DOCUMENT d584537d10q_htm.xml XML 1185146
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 211156760
SIC: 2834 Pharmaceutical Preparations